搜索筛选:
搜索耗时1.5569秒,为你在为你在102,285,761篇论文里面共找到 11 篇相符的论文内容
发布年度:
[会议论文] 作者：PiaopiaoZhang;ZhongminYang;YingChen;HuiminWang;,
来源：第七届低合金高强度钢国际会议 年份：2015
Two kinds of Cr-Ni-Cu low alloyed steels were designed,0.1%C-0.7%Cr-1.2%Ni-0.7Cu and 0.1%C-0.7%Cr-0.3%Ni-0.5Cu.With the method of SEM,XRD and electrochemica...
[期刊论文] 作者：YanjunZhang,YinanZhang,XinghuFu,HuiminWang,
来源：光电工程 年份：2017
...
[期刊论文] 作者：YanjunZhang,YongshengTian,XinghuFu,WeihongBi,YinanZhang,HuiminWang,
来源：光电工程 年份：2017
...
Chemotherapyisalsoanon-negligibleaspectofnon-smallcelllungcancer(NSCLC)treatmentinera
[会议论文] 作者：JianlinXu,BoJin,TianqinChu,YuqingLou,XueyanZhang,HuiminWang,BaohuiHan,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 ThediscoveryofEGFRasadrivinggeneinNSCLCheraldedthebeginningoftheeraofprecisionmedicineforNSCLC.ThisarticlereportedtreatmentpatternsandoutcomesofpatientswhoreceivedEGF...
[会议论文] 作者：AiqinGU;BaohuiHAN;RongLI;LiwenXIONG;HuiminWANG;ChunleiSHI;ZhiqiangGAO;ZHANGXue-Yan;,
来源：上海市肺科学会和美国ACCP联合会议 年份：2011
肺癌是最常见的恶性肿瘤之一，肺癌发病率及死亡率逐年提高。非小细胞肺癌（non-small cell lung cancer， NSCLC)占肺癌的80％以上，但70%以上的肺癌患者在确诊时已为不能手术切除...
EGFRtyrosinekinaseinhibitorsversuschemotherapyasfirst-linetherapyfornon-smallcelllungca
[会议论文] 作者：JianlinXu,HaitangYang,BoJin,TianqinChu,XueyanZhang,YuqingLou,HuiminWang,BaohuiHan,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 TheefficacyofEGFRtyrosinekinaseinhibitors(TKIs)variesamongdifferentEGFRmutations.Here,wedirectlycomparedtheefficacyoffirst-lineTKIstochemotherapyfornon-smallcelllungcance...
Downregulation of miR-544 in tissue, but not serum, is a novel biomarker of malignant transformation
[会议论文] 作者：Ruimin Ma,Guojun Zhang,HuiminWang,Hong Lv,Fang Fang,Xixiong Kang,
来源：2012北京检验医学年会暨中青年检验医学论坛 年份：2012
Low-grade glioma inherently tends to progress to anaplastic astrocytoma and eventually secondary glioblastoma, and the malignant transformation may involve the accumulation of multiple genetic alterat...
FactorsthatPredictProgression-freeSurvivalinChineseLungAdenocarcinomaPatientsTreatedwith
[会议论文] 作者：ShaohuaCui,LiwenXiong,YuqingLou,HuangpingShi,AiqinGu,YizhuoZhao,TianqingChu,HuiminWang,WeiZhang,LiliDong,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 Althoughfirst-generationepidermalgrowthfactorreceptortyrosinekinaseinhibitors(EGFR-TKIs)haveshownefficacyinpatientswithadvancedlungcancers,survivalpredictorswiththesedrugsha...
Combination of chemotherapy and gefitinib as first-line treatment of patients with advanced lung ade
[会议论文] 作者：BaohuiHan,BoJin,TianqinChu,YanjieNiu,HuaZhong,YuDong,AiqingGu,HuiminWang,XueyanZhang,PingGu,YuqingLou,
来源：2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 年份：2016
目的 To explore the optimal treatment strategy for patients who harbored a sensitive EGFR mutation.We did a head-to-headstudy to compare chemotherapy and gefitinib in combination with either agent alone...
[会议论文] 作者：HuiminWang[1]XiaomingXu[2]YingxinZhang[2]XiaodengZhan[2]XihongShen[2]JianlinWan[3]LiyongCao[2]ShihuaCheng,
来源：中国作物学会2013年学术年会 年份：2013
Heading date (HD) is a critical trait for adaptation to different cultivation areas and cropping season and it is one of the leading objectives in rice bree...
Mapping of QTLs associated with grain type traits using three populations from a super hybrid rice X
[会议论文] 作者：HuiminWang[1]ShihuaCheng[2]YongshuLiang[2]XiaomingXu[3]RongrongZhai[2]GaoxingDai[4]ZhanlieYang[5]YingxinZhang,
来源：中国作物学会2012年学术年会 年份：2012
Xieyou9308 is a commercial super hybrid rice released in 1996 in China.In order to clarify its genetic mechanism underlying high yield potential,a recombinant i...
相关搜索：
